We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
On August 6 and 7, 2019, USP hosted the Second Annual Workshop to explore current trends, initiatives and regulations for quality compounding. Members of the West Pharmaceutical Services, Inc. (West) Scientific Affairs and Strategic Marketing departments participated in the USP workshop and gained valuable insight into the key elements of the FDA’s efforts to improve the quality of compounded drugs.
On May 30, 2015, West employees in Germany donated their time and manpower to support two local non-profit organizations—<a href="http://www.pferde-staerken-online.de/"><span style="text-decoration: underline;">Kids auf Trab</span></a> and <a href="http://zwischenuns-filzbluete.de/?page_id=371"><span style="text-decoration: underline;">Zwischen Uns e.V.</span></a>—with a community day, held under the patronage of Rudi Bertram, mayor of Eschweiler.
West Pharmaceutical Services, Inc. celebrated its 25th anniversary in Stolberg, Germany on September 12, 2015. It was a special occasion for all in attendance and a good opportunity for employees to get together away from day-to-day business operations.
Selecting the best vial container closure system (CCS) components and capping process for a drug product ensures optimal performance and patient safety. An optimized CCS requires compatible components (rubber stopper, aluminum seal, glass or polymer vial) and proper capping setup. This provides predictable sealing performance, which maintains the container closure integrity (CCI) needed for patient safety and visual acceptance.
<p>Demand is increasing for Daikyo’s sterile, ready to use closure components, known as Daikyo RUV® (Ready to Use Validated) components. Against that background, Daikyo has significantly expanded its packaging component sterilization operations to meet the needs of smaller customers as well as large scale pharmaceutical companies. By adopting an approach that replicates its existing footprint, Daikyo has been able to manage validation risks effectively, while meeting an ambitious timeline for bringing on new autoclave capacity. The result of this expansion is a state-of-the-art facility that triples the company’s previous sterilization capacity.</p>
English
Chinese
